External pharmaceutical composition and methods of use
    1.
    发明授权
    External pharmaceutical composition and methods of use 失效
    外用药物组成及使用方法

    公开(公告)号:US4789667A

    公开(公告)日:1988-12-06

    申请号:US771764

    申请日:1985-09-03

    摘要: A pharmaceutical composition for external use with the enhanced penetration of a pharmacologically active agent through the skin or mucosa of a warm-blooded animal, said composition comprising(A) a pharmaceutically effective amount of the pharmacologically active agent, and(B) an optically active or inactive pyroglutamate of the following formula ##STR1## wherein R represents a linear, branched or cyclic alkyl or alkenyl group having 10 to 14 carbon atoms,as a penentration enhancer.

    摘要翻译: 一种外用的药物组合物,其具有通过温血动物的皮肤或粘膜增强的药理活性剂渗透性,所述组合物包含(A)药学有效量的药理活性剂,和(B)光学活性剂 或不活泼的焦谷氨酸盐,其中R表示具有10至14个碳原子的直链,支链或环状烷基或烯基作为缩合增强剂。

    1.alpha.,24-(OH).sub.2 -cholecalciferol emulsion composition and method
for treating psoriasis
    2.
    发明授权
    1.alpha.,24-(OH).sub.2 -cholecalciferol emulsion composition and method for treating psoriasis 失效
    1α,24-(OH)2 - 胆钙化醇乳剂组合物和治疗牛皮癣的方法

    公开(公告)号:US5612327A

    公开(公告)日:1997-03-18

    申请号:US428106

    申请日:1995-04-28

    摘要: A 1.alpha.,24-(OH).sub.2 --V.D.sub.3 cream composition comprising(a) a therapeutically effective amount of 1.alpha.,24-(OH).sub.2 --V.D.sub.3,(b) an oil phase component including(i) a solid oil component composed of 5 to 20 parts by weight of white petrolatum and 5 to 15 parts by weight of higher alcohols and(ii) a liquid oil component comprising of 3 to 10 parts by weight of squalane,(c) an aqueous phase component, and(d) 2.5 to 7.5 parts by weight at least two surfactants, wherein the 1.alpha.,24-(OH).sub.2 --V.D.sub.3 cream composition has a weight ratio of the solid oil component to the liquid oil component (i.e., solid oil component/liquid oil component) of at least approximately 2, the higher alcohols are composed of stearyl alcohol and cetyl alcohol, the weight ratio of the stearyl alcohol to the higher alcohols (i.e., stearyl alcohol/higher alcohols) is approximately 0.65 to approximately 0.9, at least 50% by weight of the surfactants is at least one surfactant having an HLB value of approximately 5 or less, and the HLB value of the surfactants as a whole is approximately 8 to approximately 18.

    摘要翻译: PCT No.PCT / JP94 / 01443 Sec。 371日期:1995年4月28日 102(e)日期1995年4月28日PCT 1994年9月1日PCT公布。 公开号WO95 / 06482 日期:1995年3月9日A 1α,24-(OH)2-V.D3乳膏组合物,其包含(a)治疗有效量的1α,24-(OH)2-V.D3,(b)油相 组分包括(i)由5至20重量份的白凡士林和5至15重量份的高级醇组成的固体油组分和(ii)包含3至10重量份的角鲨烷的液体油组分( c)水相组分,和(d)2.5至7.5重量份的至少两种表面活性剂,其中所述1α,24-(OH)2-V.D3乳膏组合物具有固体油组分与 液体油组分(即固体油组分/液体油组分)至少约为2,高级醇由硬脂醇和鲸蜡醇组成,硬脂醇与高级醇的重量比(即硬脂醇/更高 醇)为约0.65至约0.9,至少50重量%的表面活性剂是至少一种HLB值为约 实际为5以下,表面活性剂整体的HLB值约为8〜18。

    Sustained release preparation
    3.
    发明授权
    Sustained release preparation 失效
    持续释放准备

    公开(公告)号:US4814176A

    公开(公告)日:1989-03-21

    申请号:US817649

    申请日:1986-01-10

    摘要: A sustained release preparation comprising:(a) chitin, chitosan, or a mixture thereof(b) anionic polymer compounds such as those having a carboxyl group, a sulfonic acid group, or a group capable of providing the same, and(c) pharmaceutically active agents.This sustained release preparation can provide the desired sustained-release or dissolution of the pharmaceutically active agents in human organs irrespective of the acidity (i.e., pH conditions) therein.

    摘要翻译: 一种持续释放制剂,其包含:(甲),壳聚糖或其混合物(b)阴离子聚合物化合物,例如具有羧基,磺酸基或能够提供相同基团的基团的阴离子聚合物化合物,和(c) 活性剂。 这种持续释放制剂可以提供药物活性剂在人体器官中的期望的缓释或溶解,而与其中的酸度(即pH条件)无关。

    Sustained release preparation
    5.
    发明授权
    Sustained release preparation 失效
    持续释放准备

    公开(公告)号:US4755544A

    公开(公告)日:1988-07-05

    申请号:US870480

    申请日:1986-06-04

    摘要: A sustained release preparation comprising:(a) a non-anionic cellulose ether(b) a methoxyethylene-maleic anhydride copolymer or the hydrolyzate thereof, and(c) pharmaceutically active agents.This sustained release preparation can provide the desired sustained-release or dissolution of the pharmaceutically active agents in human organs irrespective of the acidity (i.e., pH conditions) therein.

    摘要翻译: 一种缓释制剂,其包含:(a)非阴离子纤维素醚(b)甲氧基亚乙基 - 马来酸酐共聚物或其水解产物,和(c)药用活性剂。 这种持续释放制剂可以提供药物活性剂在人体器官中的期望的缓释或溶解,而与其中的酸度(即pH条件)无关。

    Device for administering powdery medicine
    6.
    发明授权
    Device for administering powdery medicine 失效
    药用药剂

    公开(公告)号:US5884621A

    公开(公告)日:1999-03-23

    申请号:US817250

    申请日:1997-03-24

    摘要: A device for administering a powdery medicine satisfying the requirements of portability, easy and quick operation, fabrication through simple steps, rigid structure, and economy using decreased number of parts of low cost. The device for administering a powdery medicine comprises a medicine-holding portion having at least partly flexible wall portion for defining therein a powdery medicine-container space which also serves as an air reservoir, and a medicine guide portion through which the space in said medicine-holding portion is communicated with the outside, wherein the space in said medicine-holding portion is communicated with the outside through said medicine guide portion only, said medicine guide portion is of a tubular structure having, at one end thereof, a medicine spray port at a position on the outside of said medicine-holding portion and having, at the other end thereof, a medicine suction port at a position in the space in said medicine-holding portion, the bottom of the space in said medicine-holding portion is positioned nearly just under the medicine suction port of said medicine guide portion, said medicine suction port is disposed close to said bottom, and the powdery medicine is sprayed to the outside through said medicine guide portion by depressing and relaxing the flexible wall portion of said medicine-holding portion.

    摘要翻译: PCT No.PCT / JP96 / 02097 Sec。 371日期1997年3月24日 102(e)1997年3月24日PCT PCT 1996年7月25日PCT公布。 公开号WO97 / 04826 日期1997年2月13日一种满足便携性要求,易于快速操作,通过简单步骤制造,刚性结构和经济性的粉状药物的管理装置,降低了部件成本。 用于施用粉末药物的装置包括药物保持部分,其具有至少部分柔性的壁部分,用于在其中限定也用作贮气器的粉末药物容器空间,以及药物引导部分, 保持部与外部连通,其中所述药物保持部的空间仅通过所述药物引导部与外部连通,所述药物引导部为管状结构,其一端具有药物喷雾口 在所述药物保持部的外侧的位置,并且在另一端具有在所述药物保持部的空间的位置处的药剂吸入口,所述药物保持部的所述空间的底部被定位 几乎位于所述药物引导部分的药物吸入口下方,所述药物吸入口靠近所述底部设置,粉末药物是spra 通过按压和放松所述药物保持部分的柔性壁部分,通过所述药物引导部分向外部延伸。

    Composition for solid pharmaceutical preparations of active vitamins D.sub.
3
    7.
    发明授权
    Composition for solid pharmaceutical preparations of active vitamins D.sub. 3 失效
    活性维生素D3的固体药物制剂的组合物及其制备方法

    公开(公告)号:US4729895A

    公开(公告)日:1988-03-08

    申请号:US27082

    申请日:1987-03-16

    摘要: This invention is concerned with a composition for solid pharmaceutical preparations of active vitamins D.sub.3, having the remarkably improved stability of active vitamins D.sub.3, and an extremely advantageous process for the preparation thereof from the industrial viewpoint. The composition of this invention is a composition for solid pharmaceutical preparations of active vitamins D.sub.3 prepared by forming an outer layer comprising active vitamins D.sub.3 and an excipient, which is readily soluble in an organic solvent, around an inner layer comprising an excipient which is slightly soluble in an organic solvent.

    摘要翻译: 本发明涉及活性维生素D3的固体药物制剂的组合物,具有显着提高的活性维生素D3的稳定性,并且从工业观点出发,其制备方法非常有利。 本发明的组合物是一种活性维生素D3的固体药物制剂的组合物,其通过在包含微溶性赋形剂的内层上形成包含活性维生素D3的外层和容易溶于有机溶剂的赋形剂, 在有机溶剂中。

    Multi-dose powdered medicine administering device and method thereof
    8.
    发明授权
    Multi-dose powdered medicine administering device and method thereof 失效
    多剂量粉末给药装置及其方法

    公开(公告)号:US5634900A

    公开(公告)日:1997-06-03

    申请号:US373202

    申请日:1995-01-12

    IPC分类号: A61M13/00 A61M15/00

    摘要: An administering device capable of quantitatively spraying a multi-dose of powdered medicine includes a device body (1), a storage chamber (3) detachably provided in the device body, the storage chamber (3) being capable of storing powdered medicine, the amount of which corresponds to a plurality of administering operations, an accommodation chamber (10) capable of accommodating powdered medicine, the amount of which corresponds to a single administering operation, and a medicine dispensing rotor (6) movably attached to the device body. The medicine dispensing rotor communicates the accommodation chamber with the storage chamber at a charging position (3a) and communicates the accommodation chamber with the outside of the device body at an administering position (5a) so that the powdered medicine in the accommodation chamber can be administered. A cap (20) is provided for moving the medicine dispensing rotor between the charging position and the administering position. A pump means (8) is provided for injecting air into the storage chamber through the accommodation chamber at the charging position so that the powdered medicine in the storage chamber can be stirred and a predetermined quantity of powdered medicine that has been stirred can be charged from the storage chamber to the accommodation chamber by the suction force of the pump means and/or gravity.

    摘要翻译: PCT No.PCT / JP94 / 00771 Sec。 371日期1995年1月12日 102(e)日期1995年1月12日PCT提交1994年5月12日PCT公布。 WO94 / 26338 PCT公开号 日期:1994年11月24日能够定量喷雾多剂粉末药物的给药装置包括装置本体(1),可拆卸地设置在装置主体中的储存室(3),储存室(3)能够储存 粉末药剂,其数量对应于多个给药操作,能够容纳粉末药物的容纳室(10),其量相当于单次给药操作;以及药剂分配转子(6),其可移动地附接到 装置体。 药剂分配转子将收纳室与储藏室连通在充电位置(3a),并将容纳室与装置主体的外部在给药位置(5a)连通,使得容纳室中的粉末药物能够被施用 。 提供盖(20),用于在充电位置和给药位置之间移动药物分配转子。 提供了一种泵装置(8),用于通过充电位置处的容纳室将空气喷射到储存室中,使得可以搅拌储藏室中的粉末药物,并且可以从预定量的搅拌器中加入预定量的粉末药物 通过泵装置的吸力和/或重力将储存室释放到容纳室。

    Biodegradable copolymer from hydroxy proline
    9.
    发明授权
    Biodegradable copolymer from hydroxy proline 失效
    由羟基脯氨酸生物降解的共聚物

    公开(公告)号:US5395916A

    公开(公告)日:1995-03-07

    申请号:US62335

    申请日:1993-05-17

    摘要: A biodegradable copolymer having the constituent units represented by the structures (I) and (II): ##STR1## wherein X represents a hydrogen atom, an acyl group having the formula RCO-- where R is a hydrocarbon group having 1 to 20 carbon atoms, an alkoxy group having to 20 carbon atoms, and Y represents a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, and m and n are independently integers of 1 or more, m+n is at least 10, and m/(m+n) is at least 0.01 and a pharmaceutical composition containing the same.

    摘要翻译: 具有由结构(I)和(II)表示的构成单元的生物可降解共聚物:ts氢原子,具有式RCO-的酰基,其中R是具有1至20个碳原子的烃基,烷氧基必须具有 20个碳原子,Y表示氢原子或碳原子数1〜8的烷基,m和n分别为1以上的整数,m + n为10以上,m /(m + n)为 至少0.01和含有该组合物的药物组合物。

    Extemporaneous preparation type kit of a pharmaceutical
substance-containing fat emulsion
    10.
    发明授权
    Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion 失效
    含药物脂肪乳剂的临时制剂型试剂盒

    公开(公告)号:US5229422A

    公开(公告)日:1993-07-20

    申请号:US715018

    申请日:1991-06-13

    IPC分类号: A61K9/107

    CPC分类号: A61K9/1075 Y10S514/943

    摘要: An extemporaneous kit of pharmaceutical substance-containing fat emulsion which consists of a fat emulsion and (a) a pharmaceutical substance composition containing pharmaceutical substance and at least one solvent selected from the group consisting of water, liquid polyalkylene glycols, liquid alkylethanolamines, and liquid polyhydric alcohols, or (b) a pharmaceutical substance composition containing pharmaceutical substance and saccharides and/or 30 amino acids as an excipient, and a process for preparation of a pharmaceutical substance-containing fat emulsion therefrom.

    摘要翻译: PCT No.PCT / JP88 / 00889 Sec。 371日期:1989年5月4日 102(e)日期1989年5月4日PCT提交1988年9月5日PCT公布。 出版物WO89 / 02265 日期:1989年3月23日。一种含药物脂肪乳剂的临时试剂盒,由脂肪乳液和(a)含有药物和至少一种选自水,液体聚亚烷基二醇的溶剂的药物组合物组成 ,液体烷基乙醇胺和液体多元醇,或(b)含有药物和糖类和/或30个氨基酸作为赋形剂的药物组合物及其制备含药物的脂肪乳剂的方法。